Managing Myeloma
- 2010-12-01 - For the IMF-- News Flash---ASH Meeting Planner:Webcast Alert: Continuous Therapy in Multiple Myeloma - Science Media Workshop
- 2010-12-01 - For the IMF-- News Flash---ASH Meeting Planner: Webcast Alert: Continuous Therapy in Multiple Myeloma - Science Media Workshop Mon 6th Dec
- 2010-12-01 - Pat’s Cracked Cup: Introducing My Myeloma Column And My Experiment-The Myeloma Beacon
- 2010-11-30 - Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death-7th Space Interactive
- 2010-11-30 - Experts Publish Treatment Recommendations For Multiple Myeloma Patients With Kidney Impairment-The Myeloma Beacon
- 2010-11-30 - GlaxoSmithKline Halts All Further Development Of Resveratrol Drug SRT501-The Myeloma Beacon
- 2010-11-30 - Intellikine and the Multiple Myeloma Research Consortium Initiate Phase I Trial of Targeted Drug INK128
- 2010-11-24 - Translocation t(14;16) had poor prognostic value for multiple myeloma
- 2010-11-24 - Sundar Jagannath, MD discusses Multiple myeloma -- a lesser known cancer poses challenges in diagnosis and treatment- NY Daily News
- 2010-11-19 - FDA News Release: Denosumab Approved to prevent cancer-realated bone injury in patients with solid tumors- Not approved for multiple myeloma
- 2010-11-11 - Geron Announces Two Publications Demonstrating That Its Telomerase Inhibitor Drug Targets Cancer Stem Cells
- 2010-11-11 - Pat’s Place: Living The Life Of An Average Multiple Myeloma Survivor-The Myeloma Beacon
- 2010-11-09 - Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting
- 2010-11-08 - Sibling Bond Strengthens Amid the Ordeal of Cancer-The New York Times
- 2010-11-03 - Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue-Market Watch